Acetylcholine Flashcards
Criteria for Neurotransmitters (NT) 1
Presynaptic cell should contain the substance as well as a mechanism to synthesise it
Criteria for Neurotransmitters (NT) 2
Substance should be released when depolarizing stimulus is applied to the neuron
Criteria for Neurotransmitters (NT) 3
Receptors should be present on the postsynaptic cell
Criteria for Neurotransmitters (NT) 4
Known antagonists should block the effects
Criteria for Neurotransmitters (NT) 5
A system to inactivate the substance must exist
Criteria for Neurotransmitters (NT) 6
Exogenous application of the substance to the postsynaptic cell should produce the same response
Neuromodulators can be
hormone-like (acting at a distance)
Autocrine
(self-acting)
Juxtacrine
(adjacent)
Paracrine
(near)
Endocrine
(far)
Exocrine
outside
Neuromodulators May act at locations
other than the synapse
Neuromodulators Does not
elicit a direct effect on the postsynaptic cell, but alters the action of a classical neurotransmitter
Neuromodulators May function in
anterograde or retrograde manner
Neuromodulators may be
released from glial cells
Neurons that use acetylcholine are termed
cholinergic neurons
acetylcholine is a
Common neurotransmitter at neuromuscular junctions in the periphery
Synthesis of acetylcholine
Acetyl-coA + Choline – ChAT—> acetylcholine
ChAT is only expressed in the
cytoplasm of neurons that use ACh as a neurotransmitter
Choline is derived primarily from
from hydrolysis of dietary lipids (phosphatidylcholines) by phospholipase D.
Choline is
is water soluble and is only capable of crossing the BBB due to the presence of specific choline transporters.
metabolism of acetylcholine
acetylcholine —-AChE—> choline + acetate
ACh synthesis is tightly regulated for three reasons
Product inhibition
Precursor availability (choline and acetyl-CoA)
Neuron activity (increased during high activity)
product inhibition of acetylcholine
High levels of ACh in the cell inhibit the synthesis of further ACh by ChAT
Precursor availability (choline and acetyl-CoA)
Increasing dietary choline has been explored as a treatment for conditions where the cholinergic system has been damaged (e.g. Alzheimer’s) – but not to any significant success
Neuron activity (increased during high activity)
Activity-dependent synthesis ensures sufficient ACh is available during periods of high activity
ACh Storage
Stored in vesicles at the nerve terminal by vesicular ACh transporter
ACh transport
transported by vessicles
Transport is inhibited by the drug
vesamicol Blocking vesicle transport depletes the pool of release-ready vesicles
ACh Re-uptake
ACh is broken down in the synapse to attenuate signalling
Breakdown product (choline) transported by choline transporter
Majority of choline is recycled to ACh
Re-uptake inhibited by the drug
hemicholinium-3
Botox
Local injection causes muscle paralysis by inhibiting ACh release
Insecticides and ACh
ACh is a primary neurotransmitter of the insect CNS
Plant alkyloids
secondary metabolites commonly synthesized for defense against insect or animal predation
AChE inhibition
prolongs ACh signalling
AChE inhibition decreases the rate of
ACh breakdown in the synaptic cleft leaving more ACh to act at postsynaptic receptors
Plant-derived toxin physostigmine is a
BBB permeable inhibitor of AChE (found in Calabar beans
Synthetic BBB-impermeable analogues neostigmine (Prostigmin) and pyridostigmine (Mestionon) are used to treat the
autoimmune disease myasthenia gravis (MG)
Physostigmine, pyridostigmine, and neostigmine are
reversible inhibitors of AChE
Myasthenia gravis results from
immune response to ACh receptors at neuromuscular junctions – attenuating response to ACh signals. Treatment with AChE inhibitors prolongs the ACh signal and compensates for the lost function.
malathion
inhibit AChE irreversibly
Sarin and VX
nerve gas) are irreversible AChE inhibitors
Pyridostigmine prescribed as
preventative agent to nerve gas poisoning
Pyridostigmine later found to have increased BBB permeability under stress conditions
Use linked to one component of Gulf War Syndrome
Confusion-ataxia syndrome
Cognitive impairment, dizziness, balance and coordination problems